About
Rob Cahill is a co-founder, COO, and CBO of Junevity, a longevity biotech developing siRNA therapies to restore gene networks involved in complex disease. Previously, he was founder and CEO of Jhana, a leadership-development software company acquired by FranklinCovey in 2017, and later served in an executive role at FranklinCovey. Public bios also describe prior experience with McKinsey, Sunrun, Stanford, and UCSF bioinformatics and machine learning.
Areas of interest
longevitybiotechsiRNA therapeuticsbioinformaticsmachine learningleadership developmentmanagement training